Dashboard
Manage Tickers

PHGE BiomX Inc.

NYSE biomx.com


$ 0.59 $ 0.00 (-0.29 %)    

Friday, 17-Oct-2025 15:51:01 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 0.589
$ 0.60
$ 0.55 x 100
$ 0.66 x 1,405
$ 0.57 - $ 0.63
$ 0.34 - $ 1.16
288,961
na
nm
$ 1.10
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-25-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-20-2024 03-31-2024 10-Q
7 04-04-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-29-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-10-2022 06-30-2022 10-Q
14 05-11-2022 03-31-2022 10-Q
15 03-30-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
18 05-24-2021 03-31-2021 10-Q
19 03-31-2021 12-31-2020 10-K
20 11-12-2020 09-30-2020 10-Q
21 08-13-2020 06-30-2020 10-Q
22 05-14-2020 03-31-2020 10-Q
23 03-26-2020 12-31-2019 10-K
24 10-16-2019 09-30-2019 10-Q
25 08-21-2019 06-30-2019 10-K
26 05-10-2019 03-31-2019 10-Q
27 02-06-2019 12-31-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

biomx-releases-update-for-the-fda-clinical-hold-for-us-portion-of-its-bx004-phase-2b-cystic-fibrosis-trial-receiving-written-feedback-from-fda-suggesting-potential-development-strategies-for-bx004-including-ways-to-enrich-study-populations-for-phase-3-development
BiomX Releases Update For The FDA Clinical...
10/17/2025 12:36:14

BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a clinical-stage company advancing novel natural and enginee...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/25/2025 12:08:49

Gainers PepGen (NASDAQ: PEPG) shares rose 141.0% to $6.41 during Thursday's pre-market session. The market value of their ...

hc-wainwright--co-reiterates-buy-on-biomx-maintains-15-price-target
HC Wainwright & Co. Reiterates Buy on Biom...
08/20/2025 10:38:31

HC Wainwright & Co. analyst Joseph Pantginis reiterates BiomX (AMEX:PHGE) with a Buy and maintains $15 price target.

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/19/2025 21:06:03

biomx-says-fda-places-clinical-hold-on-phase-2b-trial-of-bx004-for-treatment-of-patients-with-cystic-fibrosis
BiomX Says FDA Places Clinical Hold On Pha...
08/19/2025 12:21:16

U.S. FDA has placed a clinical hold on the Phase 2b study as it reviews data submitted by BiomX on third-party nebulizer used t...

biomx-q2-eps-019-beats-033-estimate-cash-cash-equivalents-and-restricted-cash-of-152m-are-sufficient-to-fund-its-operations-into-q1-of-2026
BiomX Q2 EPS $(0.19) Beats $(0.33) Estimat...
08/13/2025 10:32:10

Positive Phase 2 results for BX211 demonstrated >40% wound size reduction vs. placebo in diabetic foot osteomyelitis patient...

Core News & Articles
Earnings Scheduled For August 13, 2025
08/13/2025 08:32:30

what-to-expect-from-biomxs-earnings
What to Expect from BiomX's Earnings
08/12/2025 19:01:21

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/06/2025 21:07:28

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/06/2025 17:06:59

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/06/2025 12:08:40

why-astera-labs-shares-are-trading-higher-by-over-17-here-are-20-stocks-moving-premarket
Why Astera Labs Shares Are Trading Higher ...
08/06/2025 09:35:31

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/05/2025 21:07:20

Core News & Articles
BiomX Inc. 13G Filing Shows Morgan Stanley...
08/05/2025 19:31:09

https://www.sec.gov/Archives/edgar/data/1739174/000089542125000454/xslSCHEDULE_13G_X01/primary_doc.xml

biomx-initiates-phase-2b-trial-with-first-patient-dosed-in-bx004-program-for-cystic-fibrosis
BiomX Initiates Phase 2b Trial With First ...
07/14/2025 13:01:43

biomx-published-article-titled-phage-therapy-with-nebulized-cocktail-bx004-a-for-chronic-pseudomonas-aeruginosa-infections-in-cystic-fibrosis-a-randomized-first-in-human-trial-in-nature-communications
BiomX Published Article Titled "Phage ther...
07/08/2025 12:36:09

Premier research journal article provides validation for BiomX's phage therapy platform, showcasing first-in-human Phase 1b...

why-beyond-air-shares-are-trading-lower-by-over-23-here-are-20-stocks-moving-premarket
Why Beyond Air Shares Are Trading Lower By...
06/18/2025 10:14:18

wall-street-sees-3000-upside-as-this-13m-biotech-tackles-medicines-superbug-crisis-phge--the-finance-herald
'Wall Street Sees 3,000% Upside as This $1...
06/06/2025 14:17:52

https://thefinanceherald.com/wall-street-sees-3000-upside-as-this-13m-biotech-tackles-medicines-superbug-crisis-phge/

pentair-to-rally-more-than-15-here-are-10-top-analyst-forecasts-for-friday
Pentair To Rally More Than 15%? Here Are 1...
05/16/2025 14:05:02

hc-wainwright--co-maintains-buy-on-biomx-lowers-price-target-to-15
HC Wainwright & Co. Maintains Buy on BiomX...
05/16/2025 10:50:12

HC Wainwright & Co. analyst Joseph Pantginis maintains BiomX (AMEX:PHGE) with a Buy and lowers the price target from $21...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION